Skip to main navigation menu Skip to main content Skip to site footer

Research Article

Vol. 3 No. 1 (1997)

Anoxia at Birth Induces Behaviorally-Relevant Changes in alpha2-Noradrenergic Receptor Binding in the Adult Rat

  • Wayne G. Brake
  • Shakti Sharma
DOI
https://doi.org/10.26443/mjm.v3i1.587
Submitted
November 7, 2020
Published
2020-12-01

Abstract

Evidence suggests that Caesarean section birth in the rat, with or without an additional period of anoxia, results in long-term changes in brain catecholamine levels as well as reactivity to stress. The purpose of the present investigation was to determine whether Caesarean birth plus anoxia alters (alpha)2-noradrenergic receptor binding and sensitivity to the (alpha)2 receptor agonist, clonidine, in the Porsolt forced swim test. Sprague Dawley rat dams were decapitated and the uteruses were removed by Caesarean section. Pups were then delivered either immediately (Caesarean Only group), or were immersed in a saline bath for approximately 15 minutes (Caesarean plus Anoxia group) before delivery of the pups. A third group of animals born vaginally served as controls (Vaginally-born group). Four to five months postnatally, the expression of (alpha)2 receptors was measured by receptor autoradiography using [3H]-Rauwolscine binding. Receptor binding was increased in the area of the ventral hypothalamus and decreased in the CA1 region of the hippocampus in animals subjected to Caesarean plus Anoxia at birth. These animals also displayed a subsensitive response to the immobilizing effects of clonidine (100 micrograms/kg, i.p.) in the Porsolt forced swim test. Specifically these data show that Caesarean birth produces long-term changes in (alpha)2 receptor density and that, in animals subjected to Caesarean plus anoxia, these changes are reflected in a behavioral subsensitivity to the (alpha)2 agonist, clonidine. The findings reported here provide further experimental support for the hypothesis that birth complications may contribute to the pathophysiology of disorders such as schizophrenia that involve central catecholamine dysfunction.

References

  1. Brixey SN, Gallagher BJ, McFalls JA et al. Gestational and neonatal factors in the etiology of schizophrenia. Journal of Clinical Psychology 49(3): 447-456; 1993.
  2. DeLisi LE, Dauphinais ID, and Gershon ES. Perinatal complications and reduced size of brain limbic structures in familial schizophrenia. Schizophrenia Bulletin 14(2): 185-191; 1988.
  3. Günther-Genta F, Bovet P, Hohlfeld P. Obstetric complications and schizophrenia. A case-control study. British Journal of Psychiatry 164(2): 165-170; 1994.
  4. Lewis SW, Murray RM. Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. Journal of Psychiatric Research 21(4): 413-421; 1987.
  5. Norman RM, Malla AK. Stressful life events and schizophrenia I: a review of the research. British Journal of Psychiatry 162: 161-166; 1993.
  6. O'Callaghan E, Gibson T, Colohan HA, et al. Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. British Medical Journal 305(6864): 1256-1259; 1992.
  7. Pollack M, Woerner MG, Goodman W, et al. Childhood development patterns of hospitalized adult schizophrenic and non-schizophrenic psychiatric patients and their siblings. American Journal of Orthopsychiatry 36(3): 510-517; 1966.
  8. Pollin W, Stabenau JR. Biological, psychological, and historical differences in a series of monozygotic twins discordant for schizophrenia. In: Rosenthal D, Kelly SS, eds. The Transmission of Schizophrenia. Oxford: Pergamon Press; 1968.
  9. Verdoux H, Bourgeois M. A comparative study of obstetric history in schizophrenics, bipolar patients and normal subjects. Schizophrenia Research 9(1): 67-69; 1993.
  10. Woerner MG, Pollack M, Klein DF. Pregnancy and birth complications in psychiatric patients: a comparison of schizophrenics and personality disorder patients with their siblings. Acta Psychiatrica Scandinavica 49(6): 712-721; 1973.
  11. Connell PH. Amphetamine Psychosis. London: Chapman & Hall; 1958.
  12. Davis KL, Kahn RS, Ko G, et al. Dopamine in schizophrenia: a review and reconceptualization. American Journal of Psychiatry 148(11): 1474-1486; 1991.
  13. Lieberman JA, Kinon BJ, Loebel AD. Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophrenia Bulletin, 16(1), 97-110; 1990.
  14. Seeman P, Chau-Wong M, Tedesco J, et al. Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proceedings of the National Academy of Sciences, U.S.A. 72(11): 4376-4380; 1975.
  15. Seeman P, Lee T, Chau-Wong M, et al. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261(5562): 717-719; 1976.
  16. Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192(4238): 481-483; 1976.
  17. Farley I, Price KS, Deck JH, et al. Norepinephrine in chronic paranoid schizophrenia: Above-normal levels in limbic forebrain. Science 200(4340): 456-458; 1978.
  18. Farley IJ, Shannak KS, Hornykiewicz O. Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity. Advances in Biochemical and Psychopharmacology 21: 427-433; 1980.
  19. Gomes UC, Shanley BC, Potgieter L, et al. Noradrenergic overactivity in chronic schizophrenia: Evidence based on cerebrospinal fluid noradrenalin and cyclic nucleotide concentrations. British Journal of Psychiatry 137: 346-351; 1980.
  20. Kemali D, Maj M, Galderisi S, et al. Factors associated with increased noradrenalin levels in schizophrenic patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 14(1): 49-59; 1990.
  21. Kemali D, Vecchio MD, Maj M. Increased noradrenalin levels in CSF and plasma of schizophrenic patients. Biological Psychiatry 17(6): 711-717; 1982.
  22. Lake CR, Sternberg DE, Van Kammen DP, et al. Schizophrenia: elevated cerebrospinal fluid norepinephrine. Science 207(4428): 331-333; 1980.
  23. Bjelke B, Andersson K, Ögren SO, et al. Asphytic lesion: proliferation of tyrosine hydroxylase immunoreactive nerve cell bodies in the rat substantia nigra and functional changes in dopamine neurotransmission. Brain Research 543(1): 1-9; 1991.
  24. Loidl CF, Herrera-Marschitz M, Andersson K, et al. Long-term effects of perinatal asphyxia on basal ganglia neurotransmitter systems studied with microdialysis in rat. Neuroscience Letters 175(1-2): 9-12; 1994.
  25. Dell'Anna E, Chen Y, Loidl F, et al. Short-term effects of perinatal asphyxia studied with Fos immunocytochemistry and in vivo microdialysis in the rat. Experimental Neurology 131(2): 279-287; 1995.
  26. Brake WG, Noel MB, Boksa P, et al. Influence of perinatal factors on the nucleus accumbens dopamine response to repeated stress during adulthood: an electrochemical study in the rat. Neuroscience 77: 1067-1076; 1997.
  27. Brake WG, Boksa P, Gratton A. Anoxia at birth enhances sensitization to the locomotor stimulant effect of amphetamine in the adult rat. Psychopharmacology (In press).
  28. Brady LS. Stress, antidepressant drugs, and the locus coeruleus. Brain Research Bulletin 35(5-6): 545-556; 1994.
  29. Porsolt RD, Anton G, Blavet N, et al. Behavioral despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology 47(4): 379-391; 1978.
  30. Parale MP, Kulkarmi SK. Clonidine - induced behavioral despair in mice: reversal by antidepressants. Psychopharmacology 89(2): 171-174; 1986.
  31. Aston-Jones G, Foote SL, Bloom FE. Anatomy and physiology of the locus coeruleus neurons: Functional implications. In: Ziegler MG, Lake CR, eds. Norepinephrine. Frontiers of Clinical Neuroscience, Vol. 2. Baltimore: Williams & Wilkins; 1984.
  32. Zaborszky L. Afferent connections to the medial basal hypothalamus. Advances in Anatomy, Embryology and Cell Biology. 69: 1-107; 1982.
  33. Everitt BJ, Meister B, Hökfelt T. The organization of monoaminergic neurons in the hypothalamus in relation to neuroendocrine integration. In: Nemeroff CB, ed. Neuroendocrinology. Boca Raton ; CRC Press; 1992.
  34. Yirmiya R, Shavit Y, Ben-Eliyahu, S. et al. Modulation of immunity and neoplasia by neuropeptides released by stressors. In: McCubbin JA, Kaufmann PG, Nemeroff CB, eds. Stress, Neuropeptides, and Systemic Disease. San Diego: Academic Press; 1991.
  35. El-Khodor BF, Boksa P. Long-term reciprocal changes in dopamine levels in prefrontal cortex versus nucleus accumbens in rats born by Caesarean section compared to vaginal birth. Experimental Neurology (In press).
  36. Walters DV, Olver RE. The role of catecholamines in lung liquid absorption at birth. Pediatric Research 12: 239-242; 1978.
  37. Fisher JH, McCormack F, Park SS, et al. In vivo regulation of surfactant proteins by glucocorticoids. American Journal of Respiratory Cell and Molecular Biology 5(1): 63-70; 1991.
  38. Boksa P, Krishnamurthy A, Brooks W. Effects of a period of asphyxia during birth on spatial learning in the rat. Pediatric Research 37(4 Pt 1): 489-496; 1995.
  39. Boksa P, Krishnamurthy A, Sharma S. Hippocampal and hypothalamic type I corticosteroid receptor affinities are selectively reduced in adult rats born by a Caesarean procedure with or without an added period of anoxia. Neuroendocrinology 64(1): 25-34; 1996.
  40. Dobbing J, Sands J. Comparative aspects of brain growth spurt. Early Human Development 3: 79-83; 1979.
  41. Jilek L, Travnickova E, Trojan S. Characteristic metabolic and functional responses to oxygen deficienc in the central nervous system. In: Stave U, ed. Physiology of the Parinatal Period: Volume 2, Functional and Biochemical Development in Mammals. New York: Appleton-Century Crofts, Meredith Corporation; 1970.
  42. Romijin HJ, Hofman MA, Gramsbergen A. At what age is developing rat cortex comparable to that of the full term human baby? Early Human Development 26: 61-67; 1991.
  43. Poets CF, Stebbens VA, Richard D, et al. Prolonged episodes of hypoxemia in preterm infants undetectable by cardiorespiratory monitors. Pediatrics 95(6): 860-863; 1995.

Metrics

Metrics Loading ...